Webinars: Medical

Whirlwind of Change: How New Standards, MDR, and Brexit are Impacting Biocompatibility


Because of the COVID-19 crisis, new Medical Device Regulations (MDR) have been pushed back one year. Not only has the delay given a respite to companies not ready for increased regulations but also has put the new MDR requirements in the same time period with the impact of Brexit and new ISO 10993 requirements. This Tech Talk discusses the current status of biocompatibility submission with MDR and Brexit and explains what others are doing to get ready.

Topics include:

  • What additional requirements are in the MDR?
  • What is being required now per ISO 10993?
  • How is Brexit impacting submissions to the UK?
  • Where is the industry currently at and how many companies feel ready for their first submission?
  • What have we learned from the first submissions under MDR?
  • What are others doing now to save time and money?


Thor S. Rollins, Director, Toxicology and E&L Consulting, Nelson Labs


Lisa Arrigo, SAE Media Group